On June 24, 2025, Windtree Therapeutics, Inc. secured $150,000 from two note purchase agreements, issuing convertible promissory notes totaling $174,419, with a maturity of 12 months and an interest rate of 14%. Additionally, on the same day, the company faced a termination notice for a real estate agreement, disputing the release of $3 million in earnest money.